The MedTech veteran who scaled 1RF ablation for Barrett's Esophagus into a $40 million business takes the helm as Aqua treats ...

Seven years later, he proved the theory, showing that HPV genes are incorporated into cervical cancer cells. Subsequently, ...

"I'm sober now. I think a lot of people can learn from it. It deals with my growing up lower-middle class, being a kid not ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of biological and lifestyle factors that play a part in esophageal cancer risk. Physicians don’t ...

Lucid Diagnostics secures commercial coverage policy spanning multiple health plans for its EsoGuard esophageal DNA test: New York Saturday, August 8, 2026, 13:00 Hrs [IST] Lucid ...

Detailed price information for Castle Biosciences Inc (CSTL-Q) from The Globe and Mail including charting and trades.

Aqua Medical announced today that it named Robert "Bob" Haggerty as its new president and CEO, effective July 31, 2026.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is significantly associated with eosinophilic esophagitis ...

Parkersburg firefighters are taking a proactive stand against one of the profession’s quietest and most lethal threats, coming in this week to undergo specialized medical pre-screenings designed to ...

Let's admit it, burps are gross, even if they usually come with a sense of relief, but there's one common GI ailment that ...

Today sees the release of Travis Barker's Disney+/Hulu documentary Louder than Fear, a no-holds-barred look at his career and the 2008 plane crash that changed his life. Travis has been over this ...

Castle Biosciences (NASDAQ:CSTL) reported second-quarter 2026 revenue of $103.5 million, up 20% from the prior-year period, as growth in its TissueCypher test and other core offerings supported ...